(3R)-3-methyl-L-glutamic acid is an amino acid derivative that is a stereoisomer of glutamic acid, characterized by the presence of a methyl group at the third carbon of the side chain. This compound is classified as a non-proteinogenic amino acid, meaning it is not incorporated into proteins during translation. It exhibits properties typical of amino acids, such as the ability to form zwitterions, which are molecules that have both positive and negative charges. The presence of the methyl group influences its solubility and reactivity, potentially affecting its role in biochemical pathways. (3R)-3-methyl-L-glutamic acid may participate in various metabolic processes and could have implications in neurobiology, as glutamic acid is a key neurotransmitter. Its specific stereochemistry is crucial for its biological activity, as the orientation of functional groups can significantly impact interactions with enzymes and receptors. Overall, this compound is of interest in both research and potential therapeutic applications, particularly in the context of neurological studies.

(3R)-3-methyl-L-glutamic acid

63088-04-0: (3R)-3-methyl-L-glutamic acid is an amino acid derivative that is a stereoisomer of glutamic acid, characterized by the presence of a methyl group at the third carbon of the side chain. This compound is classified as a non-proteinogenic amino acid, meaning it is not incorporated into proteins during translation. It exhibits properties typical of amino acids, such as the ability to form zwitterions, which are molecules that have both positive and negative charges. The presence of the methyl group influences its solubility and reactivity, potentially affecting its role in biochemical pathways. (3R)-3-methyl-L-glutamic acid may participate in various metabolic processes and could have implications in neurobiology, as glutamic acid is a key neurotransmitter. Its specific stereochemistry is crucial for its biological activity, as the orientation of functional groups can significantly impact interactions with enzymes and receptors. Overall, this compound is of interest in both research and potential therapeutic applications, particularly in the context of neurological studies.

CAS 63088-04-0

(3R)-3-methyl-L-glutamic acid

(±)-threo-3-Methylglutamic acid

Ref: TM-T22485